Semnur Pharmaceuticals, Inc.
SMNRW- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001913577
No open-market purchases or sales by Semnur Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesSMNR
13F holders, Q4 2022
Institutional positions in Semnur Pharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- 0 vs. Q3 2022
- Shares held
- 7.12M
- −18.7K (−0.3%) vs. Q3 2022
- Total value
- $244.2K
- −$241.9K (−49.8%) vs. Q3 2022
- New holders
- 1
- 2 more added
- Sold out
- 1
- 1 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SMNRW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 3 | $59.8K |
| Q1 2025 | 19 | $319.8K |
| Q4 2024 | 19 | $213.6K |
| Q3 2024 | 22 | $343.3K |
| Q2 2024 | 20 | $107.8K |
| Q1 2024 | 25 | $279.6K |
| Q4 2023 | 28 | $321.3K |
| Q3 2023 | 29 | $435.8K |
| Q2 2023 | 27 | $381.8K |
| Q1 2023 | 28 | $421.2K |
| Q4 2022 | 25 | $244.2K |
| Q3 2022 | 25 | $486.1K |
| Q2 2022 | 13 | $440.0K |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Semnur Pharmaceuticals, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Susquehanna International Group, LLP | 17,600 | $528 | 0.00% | −200−1.1% | Reduced |
| Exos TFP Holdings LLC | 15,902 | $676 | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 32,191 | $1.13K | 0.00% | +32,191 | New |
| CVI Holdings, LLC | 50,000 | $1.50K | 0.00% | 00.0% | Unchanged |
| Fifth Lane Capital, LP | 72,500 | $2.54K | 0.00% | 00.0% | Unchanged |
| Meteora Capital, LLC | 68,878 | $2.93K | 0.00% | +4,670+7.3% | Added |
| Clear Street LLC | 102,499 | $4.00K | 0.00% | +4,627+4.7% | Added |
| Lynwood Capital Management Inc. | 104,500 | $5.00K | 0.01% | 00.0% | Unchanged |
| Ionic Capital Management LLC | 150,000 | $5.25K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 162,419 | $6.90K | 0.00% | 00.0% | Unchanged |
| Periscope Capital Inc. | 199,500 | $6.98K | 0.00% | 00.0% | Unchanged |
| CNH Partners LLC | 168,412 | $7.16K | 0.00% | 00.0% | Unchanged |
| Arena Investors LP | 225,000 | $7.88K | 0.01% | 00.0% | Unchanged |
| Whitebox Advisors LLC | 200,000 | $8.50K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 225,000 | $9.56K | 0.00% | 00.0% | Unchanged |
| Taconic Capital Advisors LP | 257,500 | $10.9K | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 410,000 | $12.3K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 393,423 | $16.7K | 0.00% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 465,000 | $19.8K | 0.00% | 00.0% | Unchanged |
| Atw Spac Management LLC | 470,000 | $20.0K | 0.00% | 00.0% | Unchanged |
| Context Capital Management, LLC | 605,000 | $21.0K | 0.00% | 00.0% | Unchanged |
| Shaolin Capital Management LLC | 573,900 | $24.0K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 1,400,000 | $49.0K | 0.00% | 00.0% | Unchanged |
| Mangrove Partners | 280,689 | – | – | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 470,000 | – | – | 00.0% | Unchanged |
| Spartan Fund Management Inc. | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |